Shareholder letter - Tuesday February 17, 2015
Link to document.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
February 25, 2015
RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage
February 19, 2015
RegeneRx Updates Website
February 17, 2015
RegeneRx Releases Letter to Shareholders
November 6, 2014
RegeneRx Announces Management Changes